CELLDEX THERAPEUTICS INC NEW's ticker is CLDX and the CUSIP is 15117B202. A total of 162 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $227,129 | -31.4% | 5,096 | -56.7% | 0.00% | – |
| Q3 2022 | $331,000 | -34.3% | 11,769 | -37.0% | 0.00% | -100.0% |
| Q2 2022 | $504,000 | -5.3% | 18,687 | +7.2% | 0.00% | 0.0% |
| Q1 2022 | $532,000 | -11.0% | 17,424 | +12.5% | 0.00% | 0.0% |
| Q4 2021 | $598,000 | -43.7% | 15,489 | -21.3% | 0.00% | 0.0% |
| Q3 2021 | $1,062,000 | +37.2% | 19,677 | -14.9% | 0.00% | 0.0% |
| Q2 2021 | $774,000 | +40.5% | 23,133 | -13.6% | 0.00% | 0.0% |
| Q1 2021 | $551,000 | +87.4% | 26,765 | +59.8% | 0.00% | – |
| Q4 2020 | $294,000 | +3575.0% | 16,753 | +280.8% | 0.00% | – |
| Q1 2020 | $8,000 | +100.0% | 4,400 | +145.0% | 0.00% | – |
| Q3 2019 | $4,000 | – | 1,796 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kynam Capital Management, LP | 2,600,000 | $88,218,000 | 12.13% |
| Octagon Capital Advisors LP | 759,898 | $25,783,339 | 3.59% |
| TSP Capital Management Group, LLC | 251,895 | $8,546,800 | 3.08% |
| ACUTA CAPITAL PARTNERS, LLC | 122,343 | $4,151,098 | 2.81% |
| 5AM Venture Management, LLC | 310,270 | $10,527,461 | 2.62% |
| COMMODORE CAPITAL LP | 631,665 | $21,432,393 | 2.41% |
| RTW INVESTMENTS, LP | 3,463,201 | $117,506,410 | 2.24% |
| Eversept Partners, LP | 785,740 | $26,660,158 | 2.23% |
| Redmile Group, LLC | 1,696,004 | $57,545,416 | 2.21% |
| Affinity Asset Advisors, LLC | 87,031 | $2,952,962 | 1.03% |